Mikhail Kolonin, Ph.D., is a tenured professor and the Harry E. Bovay, Jr. Distinguished University Chair in Metabolic Disease at the University of Texas, Houston, McGovern Medical School. He received his Ph.D. in molecular medicine from Wayne State University. As a postdoctoral fellow at M.D. Anderson Cancer Center, he screened combinatorial libraries in mice and cancer patients to identify peptides targeting tissue-specific cell surface protein interactions, which identified tissue-specific cell surface markers that have been pursued as drug targets in obesity and cancer. Research of his laboratory has spanned various aspects of intercellular interactions mediated by cytokines and long-chain fatty acids. Specifically, Dr. Kolonin’s group has dissected the heterogeneity of adipose stromal cells, giving rise to white and brown adipocytes. Recently his research has focused on the origins and roles of cell senescence in aging-associated diseases. The main interest of Kolonin laboratory converges on the multifaceted roles of stromal cells in healthy metabolism and pathology. His group discovered that adipose stromal cells from peritumoral fat tissue become recruited by carcinomas as progenitors of cancer-associated fibroblasts and discovered the mechanism underlying their tumor homing and cancer-promoting effects. Currently, Dr. Kolonin serves as the Director of the Center for Metabolic and Degenerative Diseases at the Institute for Molecular Medicine at UTHealth.
Mikhail Kolonin, Ph.D., is a tenured professor and the Harry E. Bovay, Jr. Distinguished University Chair in Metabolic Disease at the University of Texas, Houston, McGovern Medical School. He received his Ph.D. in molecular medicine from Wayne State University. As a postdoctoral fellow at M.D. Anderson Cancer Center, he screened combinatorial libraries in mice and cancer patients to identify peptides targeting tissue-specific cell surface protein interactions, which identified tissue-specific cell surface markers that have been pursued as drug targets in obesity and cancer. Research of his laboratory has spanned various aspects of intercellular interactions mediated by cytokines and long-chain fatty acids. Specifically, Dr. Kolonin’s group has dissected the heterogeneity of adipose stromal cells, giving rise to white and brown adipocytes. Recently his research has focused on the origins and roles of cell senescence in aging-associated diseases. The main interest of Kolonin laboratory converges on the multifaceted roles of stromal cells in healthy metabolism and pathology. His group discovered that adipose stromal cells from peritumoral fat tissue become recruited by carcinomas as progenitors of cancer-associated fibroblasts and discovered the mechanism underlying their tumor homing and cancer-promoting effects. Currently, Dr. Kolonin serves as the Director of the Center for Metabolic and Degenerative Diseases at the Institute for Molecular Medicine at UTHealth.